bioRxivBioinformaticsPreprint
ProteomeScan: A Toolkit For Target Validation By Proteome-Wide Docking And Analysis
Aryan Amit BarsainyaniD, Rishikesh Panda, Jose SiguenzaiD, Daniele MericoiD, Bharath RamsundariD
Abstract
The problem of identifying which protein target a potential drug-like molecule interacts with is crucial for both the study of existing drugs and the design of new therapeutic compounds. Despite the importance of target identification, existing computational approaches remain limited in terms of speed, accuracy, and protein target coverage. We introduce ProteomeScan, a large-scale, gene-driven computational toolkit for systematic proteome-wide scanning to uncover hidden or previously uncharacterized protein-ligand interactions. ProteomeScan leverages cloud-scale high performance computing to perform extensive molecular docking simulations across the human proteome to rank candidate targets based on binding affinities. After filtering promiscuous targets, we found that ProteomeScan ranks known target significantly better than a random baseline for a set of control compounds. Furthermore, we performed physical analyses of predicted binding modes for both promiscuous and known protein-ligand binding pairs to validate that ProteomeScan identifies interactions with valid binding pockets. In addition, we conducted experiments using mutant variants of proteins to study how mutations affect binding behavior. We have open sourced the core ProteomeScan algorithm as part of the DeepChem ecosystem to enhance transparency and reproducibility. Author summary
- organism: human
- assay: proteomics
- research focus: drug response / drug discovery
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- GO-Term Enrichment of Proteome-Scale Docking Profiles as a Biological Search-Space Reduction Layer for Protein Target Discovery
Chase Harms, Judith Klein‐Seetharaman·bioRxiv·Sep 22, 2026
- Blind Virtual Screening at Scale: A Scalable End-to-End Pipeline for Blind Docking and Affinity Prediction
Matthew Parks, Xin Yu, … Hok Hei Tam·bioRxiv·Oct 10, 2025
- Decoding Surface Fingerprints for Protein-Ligand Interactions
Ilia Igashov, Arian R. Jamasb, … Bruno E. Correia·bioRxiv·Apr 26, 2022
- Learning the Drug-Target Interaction Lexicon
Rohit Singh, Samuel Sledzieski, … Bonnie Berger·bioRxiv·Dec 6, 2022
- OmniBind: Proteome-Wide Promiscuity Predictions for Early-Stage Drug Screening
Josef Hanke, Sebastian Pujalte Ojeda, … Michele Vendruscolo·bioRxiv·Mar 18, 2026
- G-screen: Scalable Protein-Aware Virtual Screening through Flexible Ligand Alignment
Nuri Jung, Hahnbeom Park, … Chaok Seok·Journal of CheminformaticsPeer-reviewed·Sep 16, 2026